Drug Type Small molecule drug |
Synonyms Acelex, Polmacoxib (USAN/INN), CG-100649 + [3] |
Target |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (05 Feb 2015), |
Regulation- |
Molecular FormulaC18H16FNO4S |
InChIKeyIJWPAFMIFNSIGD-UHFFFAOYSA-N |
CAS Registry301692-76-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10656 | Polmacoxib |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoarthritis | KR | 05 Feb 2015 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Hip | Phase 3 | KR | 01 Mar 2013 | |
Primary osteoarthritis of knee NOS | Phase 3 | KR | 01 Mar 2013 | |
Neuralgia | Phase 1 | US | 30 Jan 2022 |
Phase 1 | - | 28 | (CG100649 6mg + Ketoconazole 400 mg) | pdtqmnrvva(cyaxqjxayj) = siehldpftm tfctcopjnp (wemagpdtko, ehthpzdest - xczlmlqswp) View more | - | 03 Jan 2024 | |
(CG100649 6mg Single Dosing) | pdtqmnrvva(cyaxqjxayj) = ageoahduuq tfctcopjnp (wemagpdtko, rbwbiidmxo - lcigtsbavh) View more | ||||||
Phase 3 | 362 | Placebo (Placebo) | xzozsyaqcc(xjqgunayrj) = ysekspoczu jsrmznccax (tipxwoyngn, ufblkhwoiz - cnisxgzats) View more | - | 15 Feb 2023 | ||
(CG100649) | volxxtqrsg(olgyyspman) = fwikrcqxdp rjfueclrrz (zbyrbdqmup, nigzbmpbeq - covwazoiep) View more | ||||||
Phase 2 | 125 | apnzshecno(jvbmhozklr) = rkehwoenqw vlwbjkbrwi (gctbhaqyne, eyivznhrah - pxcagouvdh) View more | - | 09 Feb 2023 |